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It has been estimated that 1 to 2% of the population in developed countries will 
experience a chronic wound over their lifespan.[1] Occurrence of chronic wounds are 
particularly common in growing elderly populations and those who are suffering from 
diabetes and obesity.[2] While there are several phases in wound healing (i.e., coagulation, 
inflammation, proliferation, and remodeling),[3–6] chronic wounds are typically the result of 
prolonged and/or uncontrolled inflammation.[2,7]  Despite this, inflammation is an 
indispensable step in the wound healing process and sets the stage for proper regeneration by 
staving off infection, clearing the wound site of debris, and recruiting cells to the wound that 
play critical roles in tissue remodeling and re-vascularization.[3,6,8,9]  In fact, studies have 
shown that suppressing the inflammatory response actually hinders proper wound healing.[4,10] 
Macrophages play a key role in regulating the inflammatory response and in directing the 
transition to later stages of the wound healing process.[11–17]  We and others believe that 
regulating the time at which macrophages transition from coordinating an inflammatory 
response (Figure 1a, Phase 1 (red)) to coordinating later pro-healing stages of the wound 
healing process (Phase 2 (blue)) may be key to understanding the role of inflammation in 
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wound healing and in developing improved treatment strategies.[18–20] For example, it is 
apparent that proper healing requires an inflammatory phase that eventually transitions into 
anti-inflammatory, pro-healing phases.[21,22] However, it remains unknown how the duration 
of this inflammatory phase (Tih) impacts or can be used to optimize wound healing outcome. 
Moreover, optimal durations are likely different for different wounds and for different patients. 
This motivates the need for biomaterials that enable flexible control over the duration of this 
inflammatory period, as both an investigative and clinical tool.  
 Here, we propose a biomaterial system designed to deliver immunomodulatory 
cytokines in a manner that can potentially regulate the inflammatory period’s duration in a 
flexible and on-demand manner. The inflammation phase can be initiated by establishing a 
population of pro-inflammatory M1 macrophages through the delivery of proteins that recruit 
macrophages and polarize them towards M1 phenotypes (Figure 1b, M0 to M1): for example, 
Monocyte Chemoattractant Protein-1 (MCP-1),[23,24] and Interferon Gamma (IFN-γ).[25] 
Transition from inflammatory to healing phases requires establishing a population of anti-
inflammatory M2 macrophages (e.g., alternatively activated M2a, Mb, and Mc phenotypes). 
This can be triggered through the delivery of other proteins at the wound site: for example, 
Interleukin-4 (IL-4),[26,27] and Interleukin-10 (IL-10),[26,27] (Figure 1b, M0/M1 to M2). Thus, it 
may be possible to regulate the duration of the inflammatory response (Tih) through initial 
deliveries of pro-inflammatory cytokines, such as MCP-1 and IFN-γ (Figure 1c, red curve), 
followed by delayed deliveries of anti-inflammatory cytokines, such as IL-4 and/or IL-10 
(Figure 1c, blue curve). Here, we will describe a two-compartment biomaterial system (Figure 
1d) designed to: (i) initially release pro-inflammatory cytokines from an outer compartment 
for the recruitment and establishment of pro-inflammatory macrophage phenotypes, (ii) allow 
for an inflammatory period to continue until, (iii) a magnetic gradient is applied that deforms 
the inner compartment, releasing anti-inflammatory cytokines, which would (iv) direct 
macrophages to take on pro-healing phenotypes. Such a material system could enable control 
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over the inflammatory period’s duration simply by applying a magnetic gradient (from simple 
hand-held magnets or electromagnets) at the time point at which one wishes inflammation to 
transition into an anti-inflammatory phase.   
 This two-compartment biomaterial system comprises an outer gelatin scaffold and an 
inner biphasic ferrogel (Figure 2a). The outer compartment exhibited an interconnected 
macroporous structure designed to permit rapid cell infiltration (Figure 2b). Also, by virtue of 
being made from gelatin (a hydrolyzed form of collagen), this gelatin scaffold presents 
binding motifs for cell binding, motility, and spreading.[28,29] For the inner compartment, we 
utilized a biphasic ferrogel with an Fe3O4-laden region on the top half of the cylindrical gel 
and an Fe3O4-free, porous, and deformable region on the bottom (Figure 2c). These biphasic 
ferrogels were designed to efficiently deform in the presence of a graded magnetic field (i.e., 
in the presence of fields emanating from simple hand-held magnets or electromagnets). When 
magnetically deformed, these gels would release molecular payloads stored in the Fe3O4-free 
region in a magnetically triggered manner. The particular ferrogel formulation adopted here (1 
wt% alginate, 7 wt% Fe3O4, 2.5 mM adipic acid dihydrazide cross-linked, freeze-dried at -
20ºC) was previously shown to be optimal in terms of providing magnetically triggered 
deliveries.[30,31]  
The outer porous gelatin scaffold was designed to provide initial deliveries of pro-
inflammatory cytokines and to recruit and permit the residence of macrophages. To test this 
compartment’s ability to recruit and establish macrophage populations, RAW 264.7 
macrophages were seeded at 10,000 cells per well in a 12-well plate on Day -1 and allowed to 
establish themselves for 24 hours as a 2-dimensional (2D) colony. Then (at Day 0), gelatin 
scaffolds (compartment 1, Figure 2b) were placed on top of 2D macrophage colonies and left 
for 10 days so that macrophages could infiltrate the volume of the scaffold (Figure 3a). On 
Day 5, some scaffolds were removed, fixed, and stained for f-actin (FITC-Phalloidin) and 
nuclei (DAPI), revealing that macrophages had infiltrated and spread within the bottom 
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volume of the gel (Figure 3b (left) and MovieS1.mov in Supporting Information). Also, by 
Day 5, some Macrophages had reached the top of the gel (Figure 3b (right))). DAPI-stained 
macrophages residing 1800 μm from the bottom of the gel (i.e., 200 μm from the top of the 2-
mm gel) were quantified using fluorescence microscopy on days 5 and 10 (Figure 3c). This 
demonstrated that the macrophage populations could establish themselves and increase in 
population through the volume of these scaffolds over the course of 10 days in vitro. It must 
be noted that these in vitro studies utilized RAW macrophages which are more proliferative 
than the native macrophages that would be recruited to this material in vivo. Thus, there is no 
way of knowing if macrophage population increase vs. time is due to migration through the 
material, proliferation, or some combination thereof. Additionally, the cell densities vs. time 
observed here (Figure 3c) are likely higher than what would be expected in vivo. However, to 
enhance macrophage populations, these scaffolds could also be loaded with cytokines that 
could potentially expedite macrophage recruitment, as well as polarize them towards M1 
phenotypes at early timepoints after implantation (e.g., MCP-1 and IFN-γ, respectively). 
These cytokines released rapidly at early time points (Figure 3d & 3e) due to excess cytokine 
being added to the outer compartment without rinsing off that excess cytokine prior to use. 
The total amount of cytokine delivered could be dictated simply by loading the scaffold with 
more or less cytokine (Figure 3d & 3e, comparing solid and dashed curves). Independent of 
loading, pro-inflammatory cytokine release ceased after roughly 12 hours (Figure S1), well 
before the times at which magnetic stimulation would be applied to trigger subsequent 
deliveries of anti-inflammatory cytokines.  
The inner compartment of this biomaterial system (Figure 2c) was designed to provide 
delayed, on-demand, and magnetically triggered delivery of anti-inflammatory cytokines (e.g., 
IL-4 and IL-10). These biphasic ferrogels were designed so that cytokines could be loaded in 
their Fe3O4-free regions and released in earnest when magnetic gradients were used to 
compress the Fe3O4-free regions (Figure 4a, white region of ferrogel compresses when a 
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hand-held magnetic is subjacently applied). See MovieS2.mov in Supporting Information for 
a movie of a biphasic ferrogel being magnetically compressed repeatedly at 1.4 Hz. Cytokine 
release rates prior to magnetic stimulation were kept at low levels by thoroughly rinsing 
ferrogels, as to remove excess cytokines that were not well-incorporated. Additionally, 
cytokine retention prior to magnetic stimulation was likely aided by the use of alginate as the 
polymeric constituent of these ferrogels. Alginate is heparin-mimicking, and heparin is known 
to bind strongly to a wide variety of cell-secreted proteins. In these studies, magnetic 
gradients were applied over the course of 3 hours, but with different temporal profiles (Figure 
4b): (i) one where a magnetic gradient was applied at a rate of 1.4 Hz continuously over 3 
hours (Stimulation Profile A, top, green) and (ii) one where a magnetic gradient was applied 
at a rate of 1.4 Hz intermittently, lasting for 5 minutes every hour for 3 hours (Stimulation 
Profile B, bottom, red). The intermittent Profile B actually yielded higher rates of cytokine 
delivery compared to the continuous Profile A (Figure 4c). This is possibly due to the fact that 
magnetic compression results in release of molecules primarily contained in the macropore 
space and not contained in the gel’s matrix (note that the Fe3O4-free region of these ferrogels 
are highly macroporous (Figure 2c)). Thus, continuous 1.4 Hz stimulation (Profile A) may 
initially purge these more available molecules from the pore space but may prohibit the 
molecules in the gel from equilibrating (i.e., molecules that were purged from the macropore 
space cannot be replaced by molecules contained in the matrix space due to constant 1.4 Hz 
gel compression). This would result in a relatively low rate of release when averaged over 3 
hours. However, intermittent stimulation (i.e., Stimulation Profile B) likely permits this re-
equilibrium of molecules in the 1 hour between subsequent magnetic compressions, resulting 
in a distribution of molecules from the matrix to the pore space. When magnetic stimulation 
continues, these relocated pore-space-molecules are efficiently purged. This may result in 
higher release rates when averaged over 3 hours. While these dynamics are outside the scope 
of this study, Stimulation Profile B has significant practical advantages in that it both 
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produces higher rates of release and would be easier to implement in vivo. That is, 5 minutes 
of 1.4 Hz stimulation every hour can be implemented by manually brining a hand-held 
magnet close to the implant site whereas 3 hours of continuous 1.4 Hz stimulation could be 
tiring if performed manually. Nevertheless, neither magnetic stimulation profile resulted in 
statistically significant changes in gel mechanics (Figure S2), suggesting that magnetic 
stimulation does not overly damage the gels. This leaves open the possibility of magnetically 
stimulating at later time points for subsequent release busts.  
 Despite the fact that Stimulation Profile A produced lower rates of release than 
Stimulation Profile B, it was nonetheless sufficient to significantly impact an anti-
inflammatory cytokine’s release profile. When loaded with 500 ng of IL-10, ferrogels 
released baseline levels of IL-10 prior to day 3 but dramatically increased release rates on day 
3 when stimulated using Magnetic Stimulation Profile A (Figure 4d, dashed curve). If this 
delayed IL-10 release was desired on day 5 rather than 3, magnetic stimulation could be 
applied on day 5 rather than day 3 (Figure 4d, solid curve). This ability to control the time at 
which anti-inflammatories are earnestly released could provide a powerful tool for 
investigating how the duration of the inflammatory response impacts wound healing outcome. 
Magnetic stimulation can also potentially be used to repetitively deliver anti-inflammatory 
cytokines on subsequent days to prevent an inflammatory response from resurging. For 
example, when loaded with 1000 ng of IL-4, baseline levels of IL-4 were released prior to 
magnetic stimulation. But, release rates were dramatically enhanced when stimulated on day 4 
using Stimulation Profile B (Figure 4e, compare slope of curve before 96 hours to the slope 
from 96 to 99 hours). The rate of IL-4 release could be subsequently enhanced on days 5 and 
6 when magnetically stimulated on those days (Figure 4e, enhanced slopes at 120 and 144 
hours). These magnetically stimulated release rates on days 4, 5, and 6 were significantly 
higher than control gels upon which no magnetic stimulation was applied (Figure 4f). These 
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studies demonstrate our ability to control the timing and rate of these anti-inflammatory 
cytokine deliveries in an on-demand, magnetically prescribed manner. 
The described biomaterial system could improve control over the inflammatory 
response in wound healing applications by locally regulating macrophage phenotype through 
carefully timed immunomodulatory cytokine deliveries. There is a growing preponderance of 
evidence suggesting that regulating macrophage phenotype vs. time is critical to achieving 
desired outcomes in wound healing and regenerative therapies,[32–36] and that sequenced 
deliveries of immunomodulatory cytokines can provide a means for this temporal 
regulation.[26,37] In fact, previous studies have designed scaffolding materials to release pro- 
and anti-inflammatory cytokines at different rates in an attempt to temporally control 
macrophage phenotype.[19,38–41] While these studies yielded promising results in their ability 
to influence macrophage phenotype in vivo, statistically significant improvements in 
regeneration were not observed (e.g., larger or more well-organized vessels/tissues). This 
could have been due to the inability to explicitly alter and optimize the timing of different 
cytokine deliveries (i.e., having the delay time of anti-inflammatory cytokines be a variable 
parameter between conditions). The biomaterial system described here could enable explicit 
control over the timing of these deliveries, without having to alter the chemistry or structure 
of the implantable scaffold material between experiments. It should be noted, however, that 
with this material system’s current formulation, macrophages initially recruited to the outer 
compartment may be exposed to baseline levels of anti-inflammatory cytokines diffusing out 
of the inner ferrogel (Figure. 4d & 4e, IL-10 and IL-4 release is non-zero prior to magnetic 
stimulation).  Even though magnetically stimulated release is significantly higher than 
diffusive release (Figure 4d & 4e, comparing slopes of curves with and without magnetic 
stimulation), if diffusive release establishes a bioactive concentration of anti-inflammatory 
cytokines, macrophages may begin to polarize towards pro-healing phenotypes prior to 
magnetic stimulation. Thus, fine-tuning of the biomaterial system will be required so that 
    Submitted to  
   8      8   
rates of release prior to magnetic stimulation result in sub-bioactive anti-inflammatory 
cytokine concentrations and release rates during magnetic stimulation result in bioactive 
concentrations. Such fine tuning can be achieved by modifying cytokine loading and ferrogel 
formulation (e.g., porosity, polymer concentration, polymer type, crosslinking density). Such 
a tuned biomaterial system will need to be tested in order to verify that this material system is 
capable of temporally regulating macrophage phenotype through magnetic stimulation.  
In sum, we have developed a biomaterial system capable of initially delivering pro-
inflammatory cytokines (MCP-1 and IFN-γ) from a macroporous gelatin structure capable of 
facilitating macrophage infiltration and growth. The amount of inflammatory cytokine release 
was dependent on the amount of cytokine loaded in the structure. This biomaterial system was 
also integrated with a biphasic ferrogel that was capable of delivering anti-inflammatory 
cytokines (IL-4 and IL-10) in a delayed and magnetically triggered manner, using common 
hand-held magnets. The rate of magnetically stimulated delivery could be regulated by using 
different magnetic stimulation profiles and the timing of delivery could be regulated simply 
by choosing when to apply magnetic stimulation. This biomaterial system thus has the 
potential to enable experimental investigations into how the rate and timing of pro- and anti-
inflammatory cytokine deliveries impact biological process critical in wound healing 
applications. Finally, this material system could also provide the material means to 
therapeutically implement optimized sequential cytokine deliveries, while retaining a high 
degree of clinical adaptability by enabling real-time alterations in delivery profiles.  
 
Experimental Section  
Fabrication and imaging of the biomaterial system: The outer compartment gelatin 
scaffolds used in these studies were purchased as 2 x 12 x 7 mm GelFoam™ sponge sheets 
(Pfizer, Groton, CT) and cut into hollow disks (2-mm tall, 8-mm OD, 4-mm ID) using 8-mm 
and 4-mm biopsy punches. Note that biopsy punches and GelFoam sponges were packaged 
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sterile for cell experiments. Additionally, they were packaged in lyophilized form, allowing 
them to be sputter-coated (30 seconds in gold) and imaged under Scanning Electron 
Microscopy (SEM) on a Zeiss SIGMA VP Field Emission-SEM with cryogenic capability 
and Energy-dispersive X-ray Spectroscopy (EDS) for elemental mapping.   
The inner ferrogel compartments were made similarly to those described in Cezar et 
al.[28] Briefly, alginate was dissolved in MES buffer (100 mM MES and 500 mM NaCl at pH 
= 6.0) containing HOBT and AAD crosslinker and was cast with iron oxide particles and 
EDC (100 mg mL-1) between two Sigmacote-treated glass plates that were separated by 2-mm 
spacers. During casting (~ 1 hour), a magnet was placed against one glass plate as to pull the 
iron oxide particles towards one side of the gel, yielding a biphasic structure. Individual 
biphasic ferrogels were cut into 4 x 2 mm disks using a biopsy punch and then washed in 50 
mL deionized water for 3 days (with water being exchanged twice a day) so that they would 
fully swell and become void of residual reagents. Ferrogels were then frozen at -20 ºC 
overnight and lyophilized. Lyophilized ferrogels were prepared for imaging by cross 
sectioning them using a sharp razor, sputter-coating in gold, and imaging as described above 
for the outer gelatin scaffolds.  
Macrophage recruitment studies: In their culture flasks, RAW 264.7 mouse 
macrophages were rinsed in PBS, resuspended in fresh DMEM, scraped off, collected, and 
plated at 10,000 cells per well on sterile 12-well plates. Macrophages were submerged in 
serum-containing DMEM and allowed to grow for 24 hours. A sterile gelatin scaffold (cut 
into a hollow disk) was then placed on top of the 2D culture in well plates (fully submerged in 
media) and left to recruit macrophages for 10 days. Macrophage-populated gelatin scaffolds 
were analyzed by fixing them in 4% PFA for 10 minutes and washed for 5 minutes in PBS, 3 
times.  Scaffolds were then soaked in a 0.2% Triton X-100/PBS solution for 5 minutes to 
permeabilize cell membranes, then washed for 5 minutes in fresh PBS, 3 times. Macrophage 
nuclei were DAPI-stained by soaking scaffolds in a 2 μg/mL solution of DAPI in PBS for 5 
    Submitted to  
   10      10   
minutes and then washing for 5 minutes in fresh PBS, 3 times. Finally, macrophage actin 
cytoskeletons were stained by soaking scaffolds in a 0.5 μg/mL solution of FITC-phalloidin in 
PBS for 5 minutes and then washing for 5 minutes in fresh PBS, 3 times.  
3D fluorescent image reconstructions were obtained by taking a green/blue confocal 
slice every 10 μm from the bottom of the scaffold to a depth of 170 μm within the scaffold 
using a Nikon TE2000E inverted confocal microscope and its associated NIS-Elements 
software package. Macrophage cell density counts were taken by inverting the gels in a fresh 
12-well plate so that the top of the gels faced down against the plate. Well plates were then 
loaded into a BioTek Cytation 3 Cell Imaging Multi-Mode Reader which was set to capture a 
blue-channel image 200 μg into the scaffold (which was 1800 μm away from the side of the 
scaffold originally near the 2D macrophage culture). BioTek Gen5 software was used to 
quantify DAPI-nuclei count from these blue-channel images.  
Magnetic stimulation of ferrogels: Ferrogels were magnetically stimulated using 0.5” 
x 0.5” x 0.5” (1.32 x 1.32 x 1.32 cm) cylindrical neodymium magnets (K&J Magnetics, 
Pipersville, PA) that were integrated into a custom stimulation apparatus that enabled 
repetitive and prolonged magnetic field exposures. The custom stimulation apparatus 
consisted of an array of cylindrical neodymium magnets place on the teetering edge of a 
variable-speed laboratory rocker’s platform (4 magnets on one edge and 4 on the opposite 
edge, see MovieS2 in supporting information).  This arrangement allowed 8 magnets to 
oscillate up and down (proximally and distally to 8 ferrogel samples) at a rate prescribed by 
the rocker’s speed. These studies all utilized the maximum rate of 1.4 Hz (i.e., one magnetic 
compression every 0.71 seconds). Ferrogels were placed in Sigmacote-treated scintillation 
vials and suspended above our custom stimulation apparatus with aluminum clamps. This 
arrangement allowed ferrogel samples to be in close proximity to the magnetics when the 
magnets were raised (though the magnets did not physically touch the vials) and far enough 
away from the magnets (~10 cm) when the magnets were lowered, allowing the ferrogels to 
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fully compress and conform back to their original un-compressed thickness between each 
cycle.  
Cytokine time course release studies: Outer compartment gelatin scaffolds were 
unpacked and punched to shape in a lyophilized state. Thus, to load them with cytokine, 
concentrated solutions of protein were prepared and added dropwise directly to the 
dehydrated scaffolds. It was determined beforehand that when adding liquid to these scaffolds 
in this manner, they could fully absorb no more than 40 μL of solution. Thus, when loading 
the scaffolds, concentrated solutions were prepared such that the desired amount of protein to 
be loaded in the scaffold be contained in 40 μL volumes (e.g., 1000 ng MCP-1 loading 
required preparation of a concentrated solution of 1000 ng MCP-1 in 40 μL of PBS). So, 
scaffolds were placed in Sigmacote-treated scintillation vials (to limit protein adsorption to 
the surfaces of the vials) and loaded dropwise with concentrated protein solutions (MCP-1 or 
IFN-γ, prepared at concentrations as described above). Scintillation vials were then capped 
and the scaffolds were left overnight at room temperature to fully absorb the protein. Time-
course release studies began after overnight protein absorption when scaffolds were 
submerged in 1 mL PBS with 1% BSA (t = 0). 1 mL samples were collected periodically from 
the vials and reserved for analysis by freezing in 1.5 mL centrifuge tubes. After sample 
removal, fresh 1 mL of PBS with 1% BSA was gently added back to the vial until the next 
sample was taken. After all samples were collected (168 hours), they were thawed and 
quantified for cytokine content using ELISA.  
 Release studies from ferrogels followed a similar procedure. As described above, 
ferrogels were prepared with the final step being lyophilization, thus producing macroporous 
and dehydrated samples. Dried ferrogels were placed in scintillation vials with the Fe3O4-free 
region facing up. It was determined beforehand that when adding liquid to these ferrogels that 
they could fully absorb no more than 20 μL of solution. They were therefore loaded using 
desired weights of protein dissolved in 20 μL of PBS (e.g., 1000 ng IL-4 in 20 μL PBS). 
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Ferrogels were left to absorb the protein overnight in capped vials. Ferrogels were then rinsed 
in PBS with 1% BSA for 3 days to remove excess unincorporated protein, which reduced 
unstimulated baseline release.  Ferrogels were then periodically sampled as described with the 
gelatin scaffolds, with sample media being fully removed and replaced with fresh media at 
each timepoint. Collected samples were quantitatively analyzed for IL-4 or IL-10 release 
using ELISA.  
Statistical Analyses: All quantitative data presented in this communication are 
represented as a mean ± standard deviation with 4 replicates (N = 4).  Because only one-to-
one statistical comparisons were made in this study (i.e., no multiple comparisons), student t-
tests (two-tailed distributions, heteroscedastic) were used to calculate p-values with p < 0.05 
being our benchmark for significance (Microsoft Excel).  
 
Supporting Information 
Additional experimental details and supplemental figures are provided in Supporting 
Information.  
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Figure 1. Regulating the inflammatory period requires initial delivery of pro-
inflammatory cytokines followed by delayed delivery of anti-inflammatory cytokines. (a) 
Schematic describing the cytokines that regulate the inflammation phase (I, red) and healing 
phase (II, blue). (b) Schematic describing how M0 macrophages can be polarized into M1 
(Pro-inflammatory) and/or M2 (Anti-inflammatory) phenotypes when exposed to different 
cytokines.  (c) Illustration of the desired cumulative release profile: initial release of 
macrophage recruitment and pro-inflammation cytokines (red), followed by delivery of anti-
inflammatory cytokines (blue). (d) Illustration of the proposed biomaterial system (top) with 
illustration key (bottom).  
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Figure 2. Two-compartment biomaterial system comprises a magnetically responsive 
biphasic ferrogel nested within an outer macroporous gelatin scaffold. (a) Photographs of 
the 2-compartment biomaterial system at an angle (top) and from the top (bottom). (b) Cross-
sectional photograph (i) and SEM micrographs (ii) of the outer porous gelatin compartment. 
(b) Cross-sectional photograph (i) and SEM microgarphs (ii) of the inner biphasic ferrogel 
compartment. Elemental map reveals the location of iron (red) and carbon (yellow-green).  
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Figure 3. The outer macroporous gelatin scaffold can recruit and harbor macrophages 
and can rapidly release pro-inflammatory cytokines. (a) Schematic detailing how 
macrophages were recruited to the gelatin scaffold and where in the scaffold different images 
and measurements were taken. (b) Left: 3D z-stack detailing DAPI- (blue) and Phalloidin- 
(green) stained macrophages in the bottom 170 μm of the scaffold on day 5. Right: collage 
image of DAPI-stained macrophages (blue) taken 1800 μm from the bottom of the gel (200 
μm from the top). (c) Quantification of macrophage density vs. time recorded 1800 microns 
from the bottom of the scaffold. (d) Cumulative release vs. time for scaffolds loaded with 
1000 ng (solid) and 100 ng (dashed) of MCP-1. (e) Cumulative release vs. time for scaffolds 
loaded with 1000 ng (solid) and 100 ng (dashed) of IFN-γ. Inset: zoomed-in cumulative 
release vs. time for scaffold loaded with 100 ng IFN-γ. Parts (c)-(e), N = 4.   
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Figure 4. The inner ferrogel compartment can produce delayed, magnetically triggered 
anti-inflammatory cytokine delivery profiles. (a) Illustration (left) and photographs (right) 
of a biphasic ferrogel before (top) and during (bottom) magnetic compression. (b) Schematics 
of the two magnetic stimulation profiles used in these studies: (top, green) a cyclic magnetic 
field of 1.4 compressions per second continuously over 3 hours and (bottom, red) the same 
exposure but pulsed so that gels are cyclically compressed for 5 minutes every hour. (c) 
Amount released after 3 hours of stimulation profile A (green) vs. B (red). (d) Cumulative IL-
4 release vs. time from ferrogels that were either magnetically stimulated on day 3 (dashed) or 
day 5 (solid). (e) Cumulative IL-10 release vs. time from ferrogels that were magnetically 
stimulated on days 4, 5, and 6. (f) Release rates over the indicated times when magnetically 
stimulated (red) vs. unstimulated (gray). For parts (c)-(f), ** and *** indicate statistically 
significant differences with p < 0.01 and 0.001, respectively (N = 4).   
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A two-compartment, magnetically responsive biomaterial system enables flexible control 
over the duration between pro- and anti-inflammatory cytokines deliveries. The system’s 
outer porous gelatin compartment can facilitate rapid infiltration and harboring of 
macrophages. The system’s outer compartment can be magnetically compressed, releasing 
payloads in earnest when stimulated with hand-held magnets. The combined 2-compartment 
system can release sequences of cytokines where the time between these two deliveries is 
controlled by the time at which a hand-held magnet is applied to the system.  
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